Evidence map›Paper›PMID 31205871›Full record

ArticleFrontiers in oncology2019

Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells.

Elena M Malinovskaya, Elizaveta S Ershova, Natalya A Okorokova, Vladimir P Veiko, Marina S Konkova, Ekaterina A Kozhina, Ekaterina A Savinova, Lev N Porokhovnik, Serguey I Kutsev, Nataly N Veiko and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The complex role of AIM2 in autoimmune diseases and cancers.Immunity, inflammation and disease · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Elena M MalinovskayaResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Elizaveta S ErshovaResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Natalya A OkorokovaBiotechnology Research Center, Bach Institute of Biochemistry, Russian Academy of Sciences, Moscow, Russia.
Vladimir P VeikoBiotechnology Research Center, Bach Institute of Biochemistry, Russian Academy of Sciences, Moscow, Russia.
Marina S KonkovaResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Ekaterina A KozhinaResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Ekaterina A SavinovaResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Lev N PorokhovnikResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Serguey I KutsevResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Nataly N VeikoResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Svetlana V KostyukResearch Centre for Medical Genetics (RCMG), Moscow, Russia.
Research Centre for Medical Genetics · RUA N Bach Institute of Biochemistry · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AIM2cfDNADAMPshuman ribosomal geneoxidized cfDNArDNATLR9

Identifiers

PMID31205871
PMCPMC6552851
OpenAlexW2947023187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.